Harvard Bioscience (HBIO) Other Non Operating Income (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Other Non Operating Income data on file, last reported at -$405000.0 in Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 109.84% year-over-year to -$405000.0 in Q1 2026; TTM through Mar 2026 was $426000.0, a 213.3% increase from a year earlier, with the FY2025 full-year figure at $507000.0, up 256.0% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$405000.0, down from $1.8 million in the prior quarter.
• Over the last five years, Other Non Operating Income for HBIO reached as high as $1.8 million in Q4 2025 and fell as low as -$644000.0 in Q2 2025.
• Historically, Other Non Operating Income has averaged -$1000.0 across 5 years, with a median of -$179000.0 in 2022.
• Across the five-year window, Other Non Operating Income soared 453.85% in 2023 and slumped 1251.11% in 2024, its largest moves.
• Year by year, Other Non Operating Income stood at $465000.0 in 2022, then sank by 171.4% to -$332000.0 in 2023, then jumped by 255.42% to $516000.0 in 2024, then jumped by 256.59% to $1.8 million in 2025, then tumbled by 122.01% to -$405000.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$405000.0 in Q1 2026, $1.8 million in Q4 2025, and -$365000.0 in Q3 2025.